Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7353432

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
54,685,000,000 JPY
72,984,000,000 JPY
55,573,000,000 JPY
Ordinary profit (loss)
9,304,000,000 JPY
8,727,000,000 JPY
12,976,000,000 JPY
Profit (loss) attributable to owners of parent
6,675,000,000 JPY
5,440,000,000 JPY
9,149,000,000 JPY
Comprehensive income
8,065,000,000 JPY
5,475,000,000 JPY
9,343,000,000 JPY
Net assets
140,137,000,000 JPY
136,836,000,000 JPY
140,704,000,000 JPY
Total assets
168,337,000,000 JPY
166,328,000,000 JPY
167,767,000,000 JPY
Basic earnings (loss) per share
177.10
68.85
144.80
243.31
84.99
Diluted earnings per share
Equity-to-asset ratio
0.832 xbrli:pure
0.819 xbrli:pure
0.835 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.